On-device cough detection and respiratory disease classification enhanced by generative data augmentation.

On-device cough detection and respiratory disease classification enhanced by generative data augmentation.

Publication date: Jun 02, 2026

Cough sounds are accessible, non-invasive biomarkers for respiratory disease assessment and can be captured using consumer-grade smartphones. Existing approaches typically focus solely on cough detection or rely on server-based deep learning for disease classification, which limits deployability and raises privacy concerns. Small, imbalanced cough datasets further hinder model generalization. To develop a multilayer, smartphone-compatible AI framework for automated cough detection and respiratory disease classification, and to propose a pioneering generative augmentation strategy utilizing a suite of five Variational Autoencoder (VAE) variants and a probabilistic cough-level fusion mechanism to improve disease classification under severe data scarcity and the limitations of conventional audio augmentation techniques. The proposed framework consists of three AI modules: (1) A Cough Detection Module (CDM) that performs real-time cough event detection and segmentation from continuous audio using lightweight models optimized for on-device execution. (2) A Disease Analysis Module (DAM) that classifies cough events into asthma, COVID-19, or healthy classes using parallel Support Vector Machine classifiers and a probabilistic cough-level fusion strategy. (3) A Generative Augmentation Module (GAM) employing five distinct VAE architectures. This module uniquely operates across the time-frequency domain for latent feature optimization while reconstructing samples in the time-domain to ensure acoustic verifiability. The CDM provides reliable segmentation across heterogeneous recording conditions. The DAM achieves strong discriminability between asthma, COVID-19, and healthy coughs using compact cepstral and spectral features. The multi-variant GAM framework demonstrates superior efficacy in alleviating class imbalance specifically, the cross-domain (time-frequency to time-domain) reconstruction allows for the clinical verification of synthetic biomarkers. All system components operate in real time on commodity Android hardware. This integrated framework addresses key limitations in dataset availability, model generalizability, and deployability, introducing an interpretable generative approach that demonstrates the feasibility of smartphone-based acoustic sensing as a scalable and privacy-preserving tool for respiratory health monitoring.

Open Access PDF

Concepts Keywords
Convolutional neural networks
Cough detection
Cough sound analysis
Generative data augmentation
On-device machine learning
Respiratory health monitoring
Support vector machines
Ubiquitous computing
Variational autoencoders
“””
// Werkzeug Debugger
EVALEX = false,
EVALEX_TRUSTED = false,
in __call__
line 1536,
NotImplementedError

Semantics

Type Source Name
disease MESH cough
disease MESH asthma
pathway KEGG Asthma
disease MESH COVID-19
drug DRUGBANK Methyltestosterone
drug DRUGBANK Coenzyme M
disease MESH respiratory sounds
disease MESH face
drug DRUGBANK Honey
disease MESH Mel
drug DRUGBANK Lincomycin
drug DRUGBANK Ademetionine
disease MESH ms5
drug DRUGBANK Albendazole
disease MESH sneezing
drug DRUGBANK Trestolone
drug DRUGBANK Tretamine
drug DRUGBANK Isoxaflutole
drug DRUGBANK L-Valine
drug DRUGBANK Pentaerythritol tetranitrate
disease MESH dis
disease MESH included
disease MESH tics
disease MESH tuberculosis
pathway KEGG Tuberculosis
disease MESH bronchitis
drug DRUGBANK Saquinavir
disease MESH heart failure
drug DRUGBANK MP4
drug DRUGBANK Aspartame
drug DRUGBANK L-Arginine
disease MESH pneumonia
drug DRUGBANK Hexocyclium
drug DRUGBANK Flavin adenine dinucleotide
disease MESH MCD
disease MESH fed
disease MESH ers
disease MESH strain
disease MESH residual blocks
drug DRUGBANK Flunarizine
disease MESH confusion
drug DRUGBANK 3-phenylpropionic acid
disease MESH ered
disease MESH cas
disease MESH lap
disease MESH char
disease MESH viral infection
drug DRUGBANK Gold
disease MESH pulmonary tuberculosis
disease MESH Respiratory diseases
disease MESH chronic cough
drug DRUGBANK Esomeprazole
disease MESH pus
disease MESH allergic rhinitis
disease MESH Park
disease MESH schizophrenia
disease MESH GAN
disease MESH CODA

Original Article

(Visited 5 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *